Join our live webinar to gain insight into how to optimize clinical trials for quality results, the benefits of the S.T.O.R.M.S checklist and much more.
Overview
Our goal is to inform the nutraceutical industry on how they can set up their clinical trials and use their microbiota data to support commercialization of their products and/or ingredients.
Objective
Learn how to leverage the microbiota and optimize your clinical trial design for quality results in this upcoming webinar. From the selection of bacteria panels to the timing of samples, from the notion of responders and non-responders to the modulation of the microbiota by the placebo, we will explore key aspects to consider when designing your clinical trial. Plus, learn how the S.T.O.R.M.S. checklist can be used as a tool to help you organize and report microbiota results.
Agenda
- Study design considerations – understanding the "Why?"
- Should the microbiota be measured?
- If yes, should it be a primary, secondary or exploratory outcome measure?
- Notion of responders and non-responders
- Can the microbiota be used in screening?
- Effect of a placebo on the microbiota
- Sampling: methods and timing
- How to take the samples
- Timing of the samples, including use of run-ins
- What to measure
- Which bacteria/panels to select
- Which metabolites to explore
- S.T.O.R.M.S. checklist
- Case study: reviewing lessons learned from a recent women's health study focusing on the vaginal microbial community
Target Audience: This webinar is aimed at all ingredient manufacturers, as well as executives and managers involved with scientific affairs and R&D for finished product brands in the neutraceutical industry and all those interested.
Language: English
Can't make a live session? Register now to automatically receive a complimentary recording after the live event.
For further information, please contact:
Jennifer Buckley
Senior Global Marketing Manager
t: +1 973 461 1498